TY  - JOUR
AU  - Hernández-Camba, A
AU  - Arranz, L
AU  - Vera, I
AU  - Carpio, D
AU  - Calafat, M
AU  - Lucendo, A J
AU  - Taxonera, C
AU  - Marín, S
AU  - Garcia, M J
AU  - Marín, G Suris
AU  - Rodríguez, E Sánchez
AU  - Carbajo, A Y
AU  - De Castro, M L
AU  - Iborra, M
AU  - Martin-Cardona, A
AU  - Rodríguez-Lago, I
AU  - Busquets, D
AU  - Bertoletti, F
AU  - Ausín, M Sierra
AU  - Tardillo, C
AU  - Malaves, J Huguet
AU  - Bujanda, L
AU  - Castaño, A
AU  - Domènech, E
AU  - Ramos, L
AU  - GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
AU  - Additional member of the Spanish GETECCU group
PY  - 2021
DO  - 10.1016/j.dld.2021.10.002
UR  - http://hdl.handle.net/10668/22154
T2  - Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
AB  - Studies to evaluate the use of mycophenolate mofetil (MMF) in inflammatory bowel disease (IBD) are limited after the appearance of biological treatments. Our primary objective was to evaluate the effectiveness and safety of MMF in IBD. IBD patients...
LA  - en
KW  - Crohn's disease
KW  - Inflammatory bowel disease
KW  - Mycophenolate mofetil
KW  - Ulcerative colitis
KW  - Chronic Disease
KW  - Colitis, Ulcerative
KW  - Crohn Disease
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - Mycophenolic Acid
KW  - Registries
TI  - Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.
TY  - research article
VL  - 54
ER  -